Not applicableUnknownNCT00563017
What this trial is testing
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Who this might be right for
Schizophrenia, CatatonicSchizophrenia, DisorganizedSchizophrenia, Paranoid+2 more
Hospital Authority, Hong Kong 30